GLP-1 receptor (GLP-1R)
Activation of GLP-1 Receptor Enhances Neuronal Base Excision Repair via PI3K-AKT-Induced Expression of Apurinic/Apyrimidinic Endonuclease 1
13
A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics
37
A comparison of three 67/68Ga-labelled exendin-4 derivatives for β-cell imaging on the GLP-1 receptor: the influence of the conjugation site of NODAGA as chelator
10
Pancreatic GLP 1 receptor activation is sufficient for incretin control of glucose metabolism in mice
16
Role and development of GLP-1 receptor agonists in the management of diabetes
13
GLP 1 receptor agonists show neuroprotective effects in animal models of diabetes
20
GLP-1 RECEPTOR ACTIVATION-BASED THERAPY; A PROMISING STRATEGY AGAINST ISCHEMIC STROKE
6
Short term monotherapy with GLP-1 receptor agonist liraglutide or PDE 4 inhibitor roflumilast is superior to metformin in weight loss in obese PCOS women: a pilot randomized study
8
Emerging role of GLP-1 receptor agonists in the treatment of obesity
11
Is there a justification for classifying GLP-1 receptor agonists as basal and prandial?
9
GLP 1 receptor agonists for Parkinson's disease (Protocol)
14
Extra Glycemic Impacts of GLP 1 Receptor Agonists: Benefits of a Class Effect?
15
Efficacy and Safety of Basal Supported Prandial GLP 1 Receptor Agonist Therapy
10
Prediction of response to GLP-1 receptor agonist therapy in Japanese patients with type 2 diabetes
8
Promotion of apoptosis in high glucose-activated hepatic stellate cells by GLP-1 receptor agonist and its potential mechanism.
7
Choosing GLP-1 Receptor Agonists or DPP-4 Inhibitors: Weighing the Clinical Trial Evidence
10
The GLP 1 receptor agonists exenatide and liraglutide activate Glucose transport by an AMPK dependent mechanism
13
Evaluating preferences for profiles of GLP-1 receptor agonists among injection-naïve type 2 diabetes patients in the UK
12
Advances in GLP-1 receptor targeting radiolabeled agent development and prospective of theranostics
25
The GIP receptor displays higher basal activity than the GLP-1 receptor but does not recruit GRK2 or arrestin3 effectively.
8